Chroma works with universities, researchers and clinicians in the UK and internationally

We are currently collaborating in the following partnerships:

International Music Therapy Assessment Consortium (IMTAC)

IMTAC is a collaboration between seven international universities and Chroma. IMTAC exists to develop, standardize and increase the implementation of assessment in music therapy. Our vision is to strengthen the field of music therapy by championing best practice examples of assessment tools. This raises the quality and ethics of clinical practice, and further strengthens interdisciplinary collaboration. IMTAC is committed to provide clear and transparent information about assessments in music therapy sessions to clients, their families and professional colleagues.

NIHR Palliative Care and Music Therapy Research Study

Chroma is working with Queens University, Belfast, Bournemouth University, Marie Curie Cancer Care and Everyday Harmony to secure funding for a NIHR multi-site study starting in 2021. The study focuses on the efficacy of music therapy for patients and families in the last weeks of life. If funded, the NIHR multi-site study hope to build on positive data from a single site study (Belfast, 2016) that the partners undertook.


Chroma is one of a number of national and international partners contributing assessment data to the development of a version of the MATADOC tool for children. This is being coordinated by music therapy researchers at The Children’s Trust and Temple University, USA.

Service Evaluations

Chroma is working with clinicians at NHS Charing Cross Hospital’s Stroke ward on a long term study investigating whether the inclusion of Neurologic Music Therapy alongside the traditional treatment modalities of OT, PT and SLT can improve and optimise patient outcomes. We report in 2021.